<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE Annotation PUBLIC "-//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN" "../GENIAtypes/GENIA_event_20.dtd">
<Annotation created="06/06/2006" annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=9341756" creator="Noriko Katsu">
<PubmedArticleSet>
<PubmedArticle>
<MedlineCitation>
<PMID>9341756</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">Induction of <term sem="Protein_family_or_group" id="T1" lex="endothelial_cell_surface_adhesion_molecule">endothelial cell surface adhesion molecules</term> by <term sem="Protein_family_or_group" id="T2" lex="tumor_necrosis_factor">tumor necrosis factor</term> is blocked by <term sem="Organic_compound_other" id="A1">protein <term sem="Amino_acid_monomer" id="T3" lex="tyrosine">tyrosine</term> <term sem="Organic_compound_other" id="T4" lex="phosphatase_inhibitor">phosphatase inhibitors</term></term>: role of the <term sem="Protein_complex" id="T5" lex="nuclear_transcription_factor_NF-kappa_B">nuclear <term sem="Protein_family_or_group" id="T6" lex="transcription_factor">transcription factor</term> <term sem="Protein_complex" id="T7" lex="NF-kappa_B">NF-kappa B</term></term>.</sentence>
<event id="E1">
<type class="Positive_regulation" />
<theme idref="T1" />
<cause idref="T2" />
<clue><clueType>Induction</clueType> <linkTheme>of</linkTheme> endothelial cell surface adhesion molecules <linkCause>by</linkCause> tumor necrosis factor is blocked by protein tyrosine phosphatase inhibitors: role of the nuclear transcription factor NF-kappa B.</clue>
</event>
<event id="E2">
<type class="Negative_regulation" />
<theme idref="E1" />
<cause idref="A1" />
<clue>Induction of endothelial cell surface adhesion molecules by tumor necrosis factor is <clueType>blocked</clueType> <linkCause>by</linkCause> protein tyrosine phosphatase inhibitors: role of the nuclear transcription factor NF-kappa B.</clue>
</event>
<event id="E3">
<type class="Regulation" />
<cause idref="T7" />
<clue>Induction of endothelial cell surface adhesion molecules by tumor necrosis factor is blocked by protein tyrosine phosphatase inhibitors: <clueType>role</clueType> <linkCause>of</linkCause> the nuclear transcription factor NF-kappa B.</clue>
<comment>NO THEME</comment>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">Recent studies from our laboratory have indicated that <term sem="Organic_compound_other" id="T8" lex="protein_tyrosine_phosphatase_(PTPase)_inhibitor"><term sem="Protein_molecule" id="T9" lex="protein_tyrosine_phosphatase">protein tyrosine phosphatase</term> <term sem="Organic_compound_other" id="A5">(<term sem="Protein_molecule" id="T10" lex="PTPase">PTPase</term>) inhibitors</term></term> can down-modulate the <term sem="Protein_family_or_group" id="T12" lex="tumor_necrosis_factor">tumor necrosis factor</term> (<term sem="Protein_family_or_group" id="T13" lex="TNF">TNF</term>)-mediated <term sem="Other" id="T11">activation</term> of the <term sem="Protein_complex" id="T14" lex="nuclear_transcription_factor_NF-kappa_B">nuclear transcription factor <term sem="Protein_complex" id="A2">NF-kappa B</term></term> in <term sem="Cell_cultured" id="T15" lex="ML-1a">ML-1a</term>, a <term sem="Cell_cultured" id="T16" lex="monocytic_cell_line">monocytic cell line</term> (Singh and Aggarwal, J. Biol. Chem. 1995: 270: 10631).</sentence>
<event uncertainty="probable" id="E4">
<type class="Negative_regulation" />
<theme idref="E5" />
<cause idref="A5" />
<clue>Recent studies from our laboratory have indicated that protein tyrosine phosphatase (PTPase) inhibitors can <clueType>down-modulate</clueType> the tumor necrosis factor (TNF)-mediated activation of the nuclear transcription factor NF-kappa B in ML-1a, a monocytic cell line (Singh and Aggarwal, J. Biol. Chem. 1995: 270: 10631).</clue>
</event>
<event id="E5">
<type class="Positive_regulation" />
<theme idref="A2" />
<cause idref="T13" />
<clue>Recent studies from our laboratory have indicated that protein tyrosine phosphatase (PTPase) inhibitors can down-modulate the tumor necrosis factor (TNF)<linkCause>-mediated</linkCause> <clueType>activation</clueType> <linkTheme>of</linkTheme> the nuclear transcription factor NF-kappa B <clueLoc>in ML-1a, a monocytic cell line</clueLoc> (Singh and Aggarwal, J. Biol. Chem. 1995: 270: 10631).</clue>
</event>
<sentence id="S3">Since <term sem="Protein_family_or_group" id="T17" lex="TNF">TNF</term> is one of the major inducers of various <term sem="Protein_family_or_group" id="T18" lex="adhesion_molecule">adhesion molecules</term> in human endothelial cells and their expression is known to require the activation of <term sem="Protein_complex" id="T19" lex="NF-kappa_B">NF-kappa B</term>, we examined the effect of <term sem="Organic_compound_other" id="T20" lex="PTPase_inhibitor"><term sem="Protein_family_or_group" id="T21" lex="PTPase">PTPase</term> inhibitors</term> on the <term sem="Protein_family_or_group" id="T23" lex="TNF">TNF</term>-mediated <term sem="Other" id="T22">induction</term> of <term sem="Protein_molecule" id="T24" lex="intracellular_adhesion_molecule_(ICAM)-1">intracellular adhesion molecule <term sem="Protein_molecule" id="A6">(ICAM)-1</term></term>, <term sem="Protein_molecule" id="T25" lex="vascular_cell_adhesion_molecule_(VCAM)-1">vascular cell adhesion molecule <term sem="Protein_molecule" id="A7">(VCAM)-1</term></term> and <term sem="Protein_molecule" id="T26" lex="endothelial_leukocyte_adhesion_molecule_(ELAM)-1">endothelial leukocyte adhesion molecule <term sem="Protein_molecule" id="A8">(ELAM)-1</term></term>.</sentence>
<event id="E42">
<type class="Positive_regulation" />
<theme idref="T18" />
<cause idref="T17" />
<clue>Since TNF is one of the major <clueType>inducers</clueType> <linkTheme>of</linkTheme> various adhesion molecules <clueLoc>in human endothelial cells</clueLoc> and their expression is known to require the activation of NF-kappa B, we examined the effect of PTPase inhibitors on the TNF-mediated induction of intracellular adhesion molecule (ICAM)-1, vascular cell adhesion molecule (VCAM)-1 and endothelial leukocyte adhesion molecule (ELAM)-1.</clue>
</event>
<event id="E43">
<type class="Gene_expression" />
<theme idref="T18" />
<clue>Since TNF is one of the major inducers of various adhesion molecules in human endothelial cells and their <clueType>expression</clueType> is known to require the activation of NF-kappa B, we examined the effect of PTPase inhibitors on the TNF-mediated induction of intracellular adhesion molecule (ICAM)-1, vascular cell adhesion molecule (VCAM)-1 and endothelial leukocyte adhesion molecule (ELAM)-1.</clue>
</event>
<event id="E44">
<type class="Positive_regulation" />
<theme idref="E43" />
<cause idref="E45" />
<clue>Since TNF is one of the major inducers of various adhesion molecules in human endothelial cells and their expression is known to <clueType>require</clueType> the activation of NF-kappa B, we examined the effect of PTPase inhibitors on the TNF-mediated induction of intracellular adhesion molecule (ICAM)-1, vascular cell adhesion molecule (VCAM)-1 and endothelial leukocyte adhesion molecule (ELAM)-1.</clue>
</event>
<event id="E45">
<type class="Positive_regulation" />
<theme idref="T19" />
<clue>Since TNF is one of the major inducers of various adhesion molecules in human endothelial cells and their expression is known to require the <clueType>activation</clueType> <linkTheme>of</linkTheme> NF-kappa B, we examined the effect of PTPase inhibitors on the TNF-mediated induction of intracellular adhesion molecule (ICAM)-1, vascular cell adhesion molecule (VCAM)-1 and endothelial leukocyte adhesion molecule (ELAM)-1.</clue>
</event>
<event uncertainty="doubtful" id="E6">
<type class="Regulation" />
<theme idref="E9" />
<cause idref="T20" />
<clue>Since TNF is one of the major inducers of various adhesion molecules in human endothelial cells and their expression is known to require the activation of NF-kappa B, we examined the <clueType>effect</clueType> <linkCause>of</linkCause> PTPase inhibitors <linkTheme>on</linkTheme> the TNF-mediated induction of intracellular adhesion molecule (ICAM)-1, vascular cell adhesion molecule (VCAM)-1 and endothelial leukocyte adhesion molecule (ELAM)-1.</clue>
</event>
<event uncertainty="doubtful" id="E7">
<type class="Regulation" />
<theme idref="E10" />
<cause idref="T20" />
<clue>Since TNF is one of the major inducers of various adhesion molecules in human endothelial cells and their expression is known to require the activation of NF-kappa B, we examined the <clueType>effect</clueType> <linkCause>of</linkCause> PTPase inhibitors <linkTheme>on</linkTheme> the TNF-mediated induction of intracellular adhesion molecule (ICAM)-1, vascular cell adhesion molecule (VCAM)-1 and endothelial leukocyte adhesion molecule (ELAM)-1.</clue>
</event>
<event uncertainty="doubtful" id="E8">
<type class="Regulation" />
<theme idref="E11" />
<cause idref="T20" />
<clue>Since TNF is one of the major inducers of various adhesion molecules in human endothelial cells and their expression is known to require the activation of NF-kappa B, we examined the <clueType>effect</clueType> <linkCause>of</linkCause> PTPase inhibitors <linkTheme>on</linkTheme> the TNF-mediated induction of intracellular adhesion molecule (ICAM)-1, vascular cell adhesion molecule (VCAM)-1 and endothelial leukocyte adhesion molecule (ELAM)-1.</clue>
</event>
<event id="E9">
<type class="Positive_regulation" />
<theme idref="A6" />
<cause idref="T23" />
<clue>Since TNF is one of the major inducers of various adhesion molecules in human endothelial cells and their expression is known to require the activation of NF-kappa B, we examined the effect of PTPase inhibitors on the TNF<linkCause>-mediated</linkCause> <clueType>induction</clueType> <linkTheme>of</linkTheme> intracellular adhesion molecule (ICAM)-1, vascular cell adhesion molecule (VCAM)-1 and endothelial leukocyte adhesion molecule (ELAM)-1.</clue>
</event>
<event id="E10">
<type class="Positive_regulation" />
<theme idref="A7" />
<cause idref="T23" />
<clue>Since TNF is one of the major inducers of various adhesion molecules in human endothelial cells and their expression is known to require the activation of NF-kappa B, we examined the effect of PTPase inhibitors on the TNF<linkCause>-mediated</linkCause> <clueType>induction</clueType> <linkTheme>of</linkTheme> intracellular adhesion molecule (ICAM)-1, vascular cell adhesion molecule (VCAM)-1 and endothelial leukocyte adhesion molecule (ELAM)-1.</clue>
</event>
<event id="E11">
<type class="Positive_regulation" />
<theme idref="A8" />
<cause idref="T23" />
<clue>Since TNF is one of the major inducers of various adhesion molecules in human endothelial cells and their expression is known to require the activation of NF-kappa B, we examined the effect of PTPase inhibitors on the TNF<linkCause>-mediated</linkCause> <clueType>induction</clueType> <linkTheme>of</linkTheme> intracellular adhesion molecule (ICAM)-1, vascular cell adhesion molecule (VCAM)-1 and endothelial leukocyte adhesion molecule (ELAM)-1.</clue>
</event>
<sentence id="S4">Like <term sem="Cell_cultured" id="T27" lex="ML-1a">ML-1a</term>, <term sem="Cell_cultured" id="T28" lex="human_dermal_microvessel_endothelial_cell">human dermal microvessel endothelial cells</term> (<term sem="Cell_cultured" id="T29" lex="MVEC">MVEC</term>) treated with <term sem="Protein_family_or_group" id="T30" lex="TNF">TNF</term> rapidly activated (within 30 min) <term sem="Protein_complex" id="T31" lex="NF-kappa_B">NF-kappa B</term>; this effect was completely abolished by co-treatment with <term sem="Organic_compound_other" id="T32" lex="phenylarsine_oxide">phenylarsine oxide</term> (<term sem="Organic_compound_other" id="T33" lex="PAO">PAO</term>), a specific inhibitor of <term sem="Protein_family_or_group" id="T34" lex="PTPase">PTPase</term>.</sentence>
<event id="E12">
<type class="Artificial_process" />
<theme idref="T29" />
<theme idref="T30" />
<clue>Like ML-1a, human dermal microvessel endothelial cells (MVEC) <clueType>treated</clueType> <linkTheme>with</linkTheme> TNF rapidly activated (within 30 min) NF-kappa B; this effect was completely abolished by co-treatment with phenylarsine oxide (PAO), a specific inhibitor of PTPase.</clue>
</event>
<event id="E13">
<type class="Positive_regulation" />
<theme idref="T31" />
<cause idref="E12" />
<clue>Like ML-1a, <clueLoc>human dermal microvessel endothelial cells (MVEC) treated with TNF</clueLoc> rapidly <clueType>activated</clueType> (<clueTime>within 30 min</clueTime>) NF-kappa B; this effect was completely abolished by co-treatment with phenylarsine oxide (PAO), a specific inhibitor of PTPase.</clue>
</event>
<event id="E14">
<type class="Negative_regulation" />
<theme idref="E13" />
<cause idref="E12" />
<cause idref="E15" />
<clue>Like ML-1a, human dermal microvessel endothelial cells (MVEC) treated with TNF rapidly activated (within 30 min) NF-kappa B; <corefTheme>this effect</corefTheme> was completely <clueType>abolished</clueType> <linkCause>by</linkCause> co-treatment with phenylarsine oxide (PAO), a specific inhibitor of PTPase.</clue>
</event>
<event id="E15">
<type class="Artificial_process" />
<theme idref="T29" />
<theme idref="T33" />
<clue>Like ML-1a, human dermal microvessel endothelial cells (MVEC) treated with TNF rapidly activated (within 30 min) NF-kappa B; this effect was completely abolished by <clueType>co-treatment</clueType> <linkTheme>with</linkTheme> phenylarsine oxide (PAO), a specific inhibitor of PTPase.</clue>
</event>
<event id="E46">
<type class="Negative_regulation" />
<theme idref="T34" />
<cause idref="T33" />
<clue>Like ML-1a, human dermal microvessel endothelial cells (MVEC) treated with TNF rapidly activated (within 30 min) NF-kappa B; this effect was completely abolished by co-treatment with phenylarsine oxide (PAO), a specific <clueType>inhibitor</clueType> <linkTheme>of</linkTheme> PTPase.</clue>
</event>
<event id="E47">
<type class="Artificial_process" />
<theme idref="T27" />
<theme idref="T30" />
<clue>Like ML-1a, human dermal microvessel endothelial cells (MVEC) <clueType>treated</clueType> <linkTheme>with</linkTheme> TNF rapidly activated (within 30 min) NF-kappa B; this effect was completely abolished by co-treatment with phenylarsine oxide (PAO), a specific inhibitor of PTPase.</clue>
<comment>CAUTION: SEE</comment>
</event>
<event id="E48">
<type class="Positive_regulation" />
<theme idref="T31" />
<cause idref="E47" />
<clue>Like <clueLoc>ML-1a</clueLoc>, human dermal microvessel endothelial cells (MVEC) <clueLoc>treated with TNF</clueLoc> rapidly <clueType>activated</clueType> (within 30 min) NF-kappa B; this effect was completely abolished by co-treatment with phenylarsine oxide (PAO), a specific inhibitor of PTPase.</clue>
<comment>CAUTION: SEE</comment>
</event>
<sentence id="S5">The induction of <term sem="Protein_molecule" id="T35" lex="ICAM-1">ICAM-1</term>, <term sem="Protein_molecule" id="T36" lex="VCAM-1">VCAM-1</term>, and <term sem="Protein_molecule" id="T37" lex="ELAM-1">ELAM-1</term> by <term sem="Protein_family_or_group" id="T38" lex="TNF">TNF</term> in <term sem="Cell_cultured" id="T39" lex="MVEC">MVEC</term> occurred within 6 h and was also completely down-regulated by <term sem="Organic_compound_other" id="T40" lex="PAO">PAO</term> in a dose-dependent manner.</sentence>
<event id="E16">
<type class="Positive_regulation" />
<theme idref="T35" />
<cause idref="T38" />
<clue>The <clueType>induction</clueType> <linkTheme>of</linkTheme> ICAM-1, VCAM-1, and ELAM-1 <linkCause>by</linkCause> TNF <clueLoc>in MVEC</clueLoc> occurred <clueTime>within 6 h</clueTime> and was also completely down-regulated by PAO in a dose-dependent manner.</clue>
</event>
<event id="E17">
<type class="Positive_regulation" />
<theme idref="T36" />
<cause idref="T38" />
<clue>The <clueType>induction</clueType> <linkTheme>of</linkTheme> ICAM-1, VCAM-1, and ELAM-1 <linkCause>by</linkCause> TNF <clueLoc>in MVEC</clueLoc> occurred <clueTime>within 6 h</clueTime> and was also completely down-regulated by PAO in a dose-dependent manner.</clue>
</event>
<event id="E18">
<type class="Positive_regulation" />
<theme idref="T37" />
<cause idref="T38" />
<clue>The <clueType>induction</clueType> <linkTheme>of</linkTheme> ICAM-1, VCAM-1, and ELAM-1 <linkCause>by</linkCause> TNF <clueLoc>in MVEC</clueLoc> occurred <clueTime>within 6 h</clueTime> and was also completely down-regulated by PAO in a dose-dependent manner.</clue>
</event>
<event id="E19">
<type class="Negative_regulation" />
<theme idref="E16" />
<cause idref="T40" />
<clue>The induction of ICAM-1, VCAM-1, and ELAM-1 by TNF in MVEC occurred within 6 h and was also completely <clueType>down-regulated</clueType> <linkCause>by</linkCause> PAO in a dose-dependent manner.</clue>
</event>
<event id="E20">
<type class="Negative_regulation" />
<theme idref="E17" />
<cause idref="T40" />
<clue>The induction of ICAM-1, VCAM-1, and ELAM-1 by TNF in MVEC occurred within 6 h and was also completely <clueType>down-regulated</clueType> <linkCause>by</linkCause> PAO in a dose-dependent manner.</clue>
</event>
<event id="E21">
<type class="Negative_regulation" />
<theme idref="E18" />
<cause idref="T40" />
<clue>The induction of ICAM-1, VCAM-1, and ELAM-1 by TNF in MVEC occurred within 6 h and was also completely <clueType>down-regulated</clueType> <linkCause>by</linkCause> PAO in a dose-dependent manner.</clue>
</event>
<sentence id="S6"><term sem="Organic_compound_other" id="T41" lex="PAO">PAO</term> was found to be effective even when added 3 h after <term sem="Protein_family_or_group" id="T42" lex="TNF">TNF</term>, suggesting a rapid mode of action of this inhibitor.</sentence>
<event id="E22">
<type class="Negative_regulation" />
<cause idref="E24" />
<cause idref="E23" />
<clue>PAO was found to be <clueType>effective</clueType> even <linkCause>when</linkCause> added 3 h <linkCause>after</linkCause> TNF, suggesting a rapid mode of action of this inhibitor.</clue>
<comment>CAUTION: be effective=down-regulation; NO THEME</comment>
</event>
<event id="E23">
<type class="Artificial_process" />
<theme idref="T41" />
<clue>PAO was found to be effective even when <clueType>added</clueType> <clueTime>3 h after TNF</clueTime>, suggesting a rapid mode of action of this inhibitor.</clue>
</event>
<event id="E24">
<type class="Artificial_process" />
<theme idref="T42" />
<clue>PAO was found to be effective even when <clueType>added</clueType> 3 h after TNF, suggesting a rapid mode of action of this inhibitor.</clue>
</event>
<sentence id="S7">Besides <term sem="Organic_compound_other" id="T43" lex="PAO">PAO</term>, other inhibitors of <term sem="Protein_family_or_group" id="T44" lex="PTPase">PTPase</term>, including <term sem="Organic_compound_other" id="T45" lex="pervanadate">pervanadate</term> and <term sem="Organic_compound_other" id="A3">diamide</term>, also blocked <term sem="Protein_family_or_group" id="T47" lex="TNF">TNF</term>-dependent <cons sem="(AND Other Other)" id="C1" lex="(AND NF-kappa_B_activation NF-kappa_b_induction)"><frag id="F1">NF-kappa B</frag> <frag id="F2">activation</frag> and <frag id="F3">induction</frag></cons> of all the three <term sem="Protein_family_or_group" id="T49" lex="adhesion_protein">adhesion proteins</term>.</sentence>
<event id="E25">
<type class="Negative_regulation" />
<theme idref="E29" />
<cause idref="T45" />
<clue>Besides PAO, <corefCause>other inhibitors of PTPase</corefCause>, including pervanadate and diamide, also <clueType>blocked</clueType> TNF-dependent NF-kappa B activation and induction of all the three adhesion proteins.</clue>
</event>
<event id="E26">
<type class="Negative_regulation" />
<theme idref="E30" />
<cause idref="T45" />
<clue>Besides PAO, <corefCause>other inhibitors of PTPase</corefCause>, including pervanadate and diamide, also <clueType>blocked</clueType> TNF-dependent NF-kappa B activation and induction of all the three adhesion proteins.</clue>
</event>
<event id="E27">
<type class="Negative_regulation" />
<theme idref="E31" />
<cause idref="T45" />
<clue>Besides PAO, <corefCause>other inhibitors of PTPase</corefCause>, including pervanadate and diamide, also <clueType>blocked</clueType> TNF-dependent NF-kappa B activation and induction of all the three adhesion proteins.</clue>
</event>
<event id="E28">
<type class="Negative_regulation" />
<theme idref="E32" />
<cause idref="T45" />
<clue>Besides PAO, <corefCause>other inhibitors of PTPase</corefCause>, including pervanadate and diamide, also <clueType>blocked</clueType> TNF-dependent NF-kappa B activation and induction of all the three adhesion proteins.</clue>
</event>
<event id="E29">
<type class="Positive_regulation" />
<theme idref="F1" />
<cause idref="T47" />
<clue>Besides PAO, other inhibitors of PTPase, including pervanadate and diamide, also blocked TNF<linkCause>-dependent</linkCause> NF-kappa B <clueType>activation</clueType> and induction of all the three adhesion proteins.</clue>
</event>
<event id="E30">
<type class="Positive_regulation" />
<theme idref="T35" />
<clue>Besides PAO, other inhibitors of PTPase, including pervanadate and diamide, also blocked TNF-dependent NF-kappa B activation and <clueType>induction</clueType> <linkTheme>of</linkTheme> <corefTheme>all the three adhesion proteins</corefTheme>.</clue>
</event>
<event id="E31">
<type class="Positive_regulation" />
<theme idref="T36" />
<clue>Besides PAO, other inhibitors of PTPase, including pervanadate and diamide, also blocked TNF-dependent NF-kappa B activation and <clueType>induction</clueType> <linkTheme>of</linkTheme> <corefTheme>all the three adhesion proteins</corefTheme>.</clue>
</event>
<event id="E32">
<type class="Positive_regulation" />
<theme idref="T37" />
<clue>Besides PAO, other inhibitors of PTPase, including pervanadate and diamide, also blocked TNF-dependent NF-kappa B activation and <clueType>induction</clueType> <linkTheme>of</linkTheme> <corefTheme>all the three adhesion proteins</corefTheme>.</clue>
</event>
<event id="E33">
<type class="Negative_regulation" />
<theme idref="E29" />
<cause idref="A3" />
<clue>Besides PAO, <corefCause>other inhibitors of PTPase</corefCause>, including pervanadate and diamide, also <clueType>blocked</clueType> TNF-dependent NF-kappa B activation and induction of all the three adhesion proteins.</clue>
</event>
<event id="E34">
<type class="Negative_regulation" />
<theme idref="E30" />
<cause idref="A3" />
<clue>Besides PAO, <corefCause>other inhibitors of PTPase</corefCause>, including pervanadate and diamide, also <clueType>blocked</clueType> TNF-dependent NF-kappa B activation and induction of all the three adhesion proteins.</clue>
</event>
<event id="E35">
<type class="Negative_regulation" />
<theme idref="E31" />
<cause idref="A3" />
<clue>Besides PAO, <corefCause>other inhibitors of PTPase</corefCause>, including pervanadate and diamide, also <clueType>blocked</clueType> TNF-dependent NF-kappa B activation and induction of all the three adhesion proteins.</clue>
</event>
<event id="E36">
<type class="Negative_regulation" />
<theme idref="E32" />
<cause idref="A3" />
<clue>Besides PAO, <corefCause>other inhibitors of PTPase</corefCause>, including pervanadate and diamide, also <clueType>blocked</clueType> TNF-dependent NF-kappa B activation and induction of all the three adhesion proteins.</clue>
</event>
<sentence id="S8">Consistent with these results, the attachment of <term sem="Cell_natural" id="A4">monocytes</term> to <term sem="Cell_cultured" id="T50" lex="MVEC">MVEC</term> was also blocked by the <term sem="Organic_compound_other" id="T51" lex="PTPase_inhibitor"><term sem="Protein_family_or_group" id="T52" lex="PTPase">PTPase</term> inhibitors</term>.</sentence>
<event id="E37">
<type class="Cell_adhesion" />
<theme idref="A4" />
<theme idref="T50" />
<clue>Consistent with these results, the <clueType>attachment</clueType> <linkTheme>of</linkTheme> monocytes <linkTheme>to</linkTheme> MVEC was also blocked by the PTPase inhibitors.</clue>
</event>
<event id="E38">
<type class="Negative_regulation" />
<theme idref="E37" />
<cause idref="T51" />
<clue>Consistent with these results, the attachment of monocytes to MVEC <clueType>was</clueType> also <clueType>blocked</clueType> <linkCause>by</linkCause> the PTPase inhibitors.</clue>
</event>
<sentence id="S9">Thus, overall, our results demonstrate that a <term sem="Protein_family_or_group" id="T53" lex="PTPase">PTPase</term> is involved either directly or indirectly in the pathway leading to the induction of <term sem="Protein_family_or_group" id="T54" lex="endothelial_cell_adhesion_molecule">endothelial cell <term sem="Protein_family_or_group" id="T55" lex="adhesion_molecule">adhesion molecules</term></term> by <term sem="Protein_family_or_group" id="T56" lex="TNF">TNF</term>.</sentence>
<event id="E39">
<type class="Positive_regulation" />
<theme idref="E40" />
<cause idref="T53" />
<clue>Thus, overall, our results demonstrate that a PTPase is <clueType>involved</clueType> either directly or indirectly <clueType>in the pathway leading</clueType> <linkTheme>to</linkTheme> the induction of endothelial cell adhesion molecules by TNF.</clue>
</event>
<event id="E40">
<type class="Positive_regulation" />
<theme idref="T54" />
<cause idref="T56" />
<clue>Thus, overall, our results demonstrate that a PTPase is involved either directly or indirectly in the pathway leading to the <clueType>induction</clueType> <linkTheme>of</linkTheme> endothelial cell adhesion molecules <linkCause>by</linkCause> TNF.</clue>
</event>
<sentence id="S10">Because of their role in <term sem="Other" id="T57" lex="cell_adhesion">cell adhesion</term>, <term sem="Protein_family_or_group" id="T58" lex="PTPase">PTPase</term> may provide a novel target of drug development for treatment of <term sem="Other" id="T59" lex="inflammation">inflammation</term>, <term sem="Other" id="T60" lex="atherogenesis">atherogenesis</term>, and <term sem="Other" id="T61" lex="tumor_metastasis">tumor metastasis</term>.</sentence>
<event id="E41">
<type class="Regulation" />
<theme idref="T57" />
<cause idref="T58" />
<clue>Because of their <clueType>role</clueType> <linkTheme>in</linkTheme> cell adhesion, PTPase may provide a novel target of drug development for treatment of inflammation, atherogenesis, and tumor metastasis.</clue>
</event>
</AbstractText>
</Abstract>
</Article>
</MedlineCitation>
</PubmedArticle>
</PubmedArticleSet>
</Annotation>
